Celanese Q2 Earnings Beat Estimates on Pricing and Execution

Zacks Investment Research News Agency

Yesterday•Zacks Investment Research

Stocks Medium Importance Neutral

Celanese Q2 Earnings Beat Estimates on Pricing and Execution

CE beats Q2 earnings and sales estimates as strong pricing, commercial execution and medical and electronics momentum lift results.

Related Symbols 1

C CE CE

Source: Zacks Investment Research

Visit Source

0 0 0

Comment

Comments

No comments yet

Be the first person to comment on this news item.

Category Stocks

Source Zacks Investment Research

Published Yesterday

Likes 0

Comments 0

Shares 0

News ID #1,083

Status Published

This news may have been collected automatically from third-party sources. Please verify important information through the original source and other reliable sources before making any trading or investment decision. This content is provided for informational purposes only and does not constitute financial advice.

Keep comments relevant to the news topic and avoid offensive, promotional, spam, or misleading content.

Celanese Q2 Earnings Beat Estimates on Pricing and Execution

Comments

User Menu